Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment
Author Type(s)
Student
Document Type
Article
Publication Date
August 2018
DOI
10.1007/s40257-017-0333-6
Journal Title
American Journal of Clinical Dermatology
Abstract
Postinflammatory hyperpigmentation (PIH) is a reactive hypermelanosis that develops following cutaneous inflammation. Common causes of PIH include intrinsic skin conditions (e.g., acne and eczema) as well as external insults to the skin, such as burn injuries and dermatologic procedures. PIH more commonly occurs in individuals with darker skin, for whom it is often a source of significant psychological distress. Several therapeutic modalities are available for the treatment of PIH, including topical agents, chemical peels, and energy-based devices. We review the epidemiology, clinical presentation, pathogenesis, and treatment of PIH.
Recommended Citation
Kaufman, B., Aman, T., & Alexis, A. (2018). Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment. American Journal of Clinical Dermatology, 19 (4), 489-503. https://doi.org/10.1007/s40257-017-0333-6
